Vincerx Pharma Inc 2024年度报告

☒ For the fiscal year endedDecember 31,2024 OR ☐TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Vincerx Pharma, Inc. (Exact name of Registrant as Specified in Its Charter) Securities registered pursuant to Section12(b) of the Act: Title of each classTradingSymbol(s)Name of each exchangeon which registeredCommon Stock, $0.0001 par value per shareVINCThe Nasdaq Stock Market LLC Securities registered pursuant to Section12(g) of the Act:None. Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act.Yes☐No☒ Indicate by check mark whether the registrant (1)has filed all reports required to be filed by Section13 or 15(d) of the Securities Exchange Act of 1934 during thepreceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2)has been subject to such filing requirements for the past 90days.Yes☒No☐ Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of RegulationS-T(§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).Yes☒No☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, anon-acceleratedfiler, a smaller reporting company, or an emerging growthcompany. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule12b-2of theExchange Act. AcceleratedFiler☐Smallerreportingcompany☒Emerginggrowthcompany☒ LargeAcceleratedFiler☐Non-Accelerated Filer☒ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revisedfinancial accounting standards provided pursuant to Section13(a) of the Exchange Act.☐ Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control overfinancial reporting under Section404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report.☐ If securities are registered pursuant to Section12(b) of the Act, indicate by check mark whether the financial statements of the registrant included in the filing reflect thecorrection of an error to previously issued financial statements.☐ Indicate by check mark whether any of those error corrections are restatements that required a recovery analysis of incentive-based compensation received by any of theregistrant’s executive officers during the relevant recovery period pursuant to§240.10D-1(b).☐ Indicate by check mark whether the registrant is a shell company (as defined in Rule12b-2of the Exchange Act).Yes☐No☒ The aggregate market value of common stock held bynon-affiliates(based on the closing sale price on The Nasdaq Capital Market on June30, 2024) was approximately$21.0million. As of March 21, 2025, there were5,234,277shares of the registrant’s common stock outstanding. Table of Contents TABLE OF CONTENTS Forward-Looking StatementsSummary Risk FactorsPARTIITEM1.BusinessITEM1A.Risk FactorsITEM1B.Unresolved Staff CommentsITEM1C.CybersecurityITEM2.PropertiesITEM3.Legal ProceedingsITEM4.Mine Safety DisclosuresPART IIITEM5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity SecuritiesITEM6.[Reserved]ITEM7.Management’s Discussion and Analysis of Financial Condition and Results of OperationsITEM7A.Quantitative and Qualitative Disclosures About Market RiskITEM8.Financial Statements and Supplementary DataITEM9.Changes in and Disagreements With Accountants on Accounting and Financial DisclosureITEM9A.Controls and ProceduresITEM9B.Other InformationITEM9C.Disclosure Regarding Foreign Jurisdictions that Prevent InspectionsPART IIIITEM10.Directors, Executive Officers and Corporate GovernanceITEM11.Executive CompensationITEM12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder MattersITEM13.Certain Relationships and Related Transactions, and Director IndependenceITEM14.Principal Accountant Fees and ServicesPART IVITEM15.Exhibit and Financial Statement SchedulesITEM16.Form10-KSummarySIGNATURESi Table of Contents Forward-Looking Statements This report contains forward-looking statements that involve risks and uncertainties. These statements relate to future periods, future events or ourfuture operating or financial plans or performance. When used in this report, the words “anticipate,” “believe,” “continue,” “could,” “estimate,”“expect,” “intends,” “forecast,” “goal,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “seeks,” “suggests,” “scheduled,”“target,” or “will,” and similar expressions are intended to identify